Is MBX Biosciences, Inc. Common Stock (MBX) a Buy, Sell, or Hold?
MBX Biosciences, Inc. Common Stock
NASDAQ:MBX
$58.8825 USD
$2.29 (4.05%)
- Volume
- 514.53K
- Average Volume
- 788.14K
- Market Capitalization
- $1.98B
- P/E Ratio
- -26.76
- Dividend Yield
- 0.00%
- Price Target
- $70.00
- Year High
- $66.55
- Year Low
- $9.63
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $30.79
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
30
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
6
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 282.47K
MBX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
MBX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Mathers Edward T | director | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Pescovitz Ora H. | director | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Heron Patrick J | director, 10 percent owner: | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Stelzer Laurie | director | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Hoerter Steven L. | director | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Ryder Steven | director | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Aynechi Tiba | director | 2026-06-04 | A-Award | 30.91 | 2026-06-05 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-08 | M-Exempt | 10.46 | 2026-05-11 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-08 | M-Exempt | 10.46 | 2026-05-11 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-08 | M-Exempt | 16 | 2026-05-11 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-08 | M-Exempt | 16 | 2026-05-11 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-08 | S-Sale | 38.3 | 2026-05-11 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-08 | S-Sale | 38.38 | 2026-05-11 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-05-06 | S-Sale | 29.54 | 2026-05-08 |
| Hawryluk P. Kent | director, officer: President & CEO | 2026-05-06 | S-Sale | 29.54 | 2026-05-08 |
| Hoerter Steven L. | director | 2026-05-01 | A-Award | 29.78 | 2026-05-04 |
| Hoerter Steven L. | director | 2026-05-01 | A-Award | 0 | 2026-05-04 |
| Hoerter Steven L. | director | 2025-11-22 | A-Award | 27.08 | 2026-04-22 |
| Hoerter Steven L. | director | 2025-11-06 | A-Award | 24.74 | 2026-04-22 |
| Smither John W | 2026-03-16 | 0 | 2026-03-18 | ||
| Hawryluk P. Kent | director, officer: President & CEO | 2026-03-13 | P-Purchase | 28.4142 | 2026-03-16 |
| Hawryluk P. Kent | director, officer: President & CEO | 2026-02-26 | M-Exempt | 16 | 2026-02-27 |
| Hawryluk P. Kent | director, officer: President & CEO | 2026-02-26 | M-Exempt | 16 | 2026-02-27 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-02-02 | A-Award | 39.07 | 2026-02-03 |
| Azoulay Salomon | officer: Chief Medical Officer | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| Bartram Richard | officer: Chief Financial Officer | 2026-02-02 | A-Award | 39.07 | 2026-02-03 |
| Bartram Richard | officer: Chief Financial Officer | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| Hawryluk P. Kent | director, officer: President & CEO | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| Hawryluk P. Kent | director, officer: President & CEO | 2026-02-02 | A-Award | 39.07 | 2026-02-03 |
| Stelzer Laurie | director | 2026-01-20 | A-Award | 43.14 | 2026-01-22 |
| Stelzer Laurie | 2026-01-20 | 0 | 2026-01-22 | ||
| Hoerter Steven L. | director | 2025-11-22 | A-Award | 27.08 | 2025-11-25 |
| Hoerter Steven L. | director | 2025-11-06 | A-Award | 24.74 | 2025-11-07 |
| Hawryluk P. Kent | director, officer: President & CEO | 2025-10-24 | M-Exempt | 3.25 | 2025-10-28 |
| Hawryluk P. Kent | director, officer: President & CEO | 2025-10-24 | M-Exempt | 3.25 | 2025-10-28 |
| Hawryluk P. Kent | director, officer: President & CEO | 2025-10-20 | P-Purchase | 13.6395 | 2025-10-21 |
| Hoerter Steven L. | director | 2025-10-17 | P-Purchase | 13.2492 | 2025-10-20 |
| Heron Patrick J | director, 10 percent owner: | 2025-09-26 | P-Purchase | 18 | 2025-09-30 |
| Mathers Edward T | director, 10 percent owner: | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| Hoerter Steven L. | director | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| Aynechi Tiba | director | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| CORNELIUS JAMES M | director | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| Ryder Steven | director | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| Heron Patrick J | director, 10 percent owner: | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| Pescovitz Ora H. | director | 2025-06-05 | A-Award | 11.86 | 2025-06-06 |
| Pescovitz Ora H. | director | 2025-04-08 | P-Purchase | 5.89 | 2025-04-10 |
| Hoerter Steven L. | director | 2025-04-07 | A-Award | 6 | 2025-04-09 |
| Hoerter Steven L. | 2025-04-07 | 0 | 2025-04-07 |